Optimum population-level use of artemisinin combination therapies: a modelling study. (2015)
Attributed to:
MRC Centre for Genomics and Global Health
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(15)00162-x
PubMed Identifier: 26545449
Publication URI: http://europepmc.org/abstract/MED/26545449
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Global health
Issue: 12
ISSN: 2214-109X